Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma

Clinical trial NCT00310518 · COMPLETED

Trial details

NCT number

NCT00310518

Sponsor

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2006-02-01

Primary completion

2007-07-01

Enrollment

30

View on ClinicalTrials.gov